"alt_sample_name"	"unique_patient_ID"	"sample_type"	"histological_type"	"primarysite"	"arrayedsite"	"summarygrade"	"summarystage"	"tumorstage"	"substage"	"grade"	"age_at_initial_pathologic_diagnosis"	"pltx"	"tax"	"neo"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"os_binary"	"relapse_binary"	"site_of_tumor_first_recurrence"	"primary_therapy_outcome_success"	"debulking"	"percent_normal_cells"	"percent_stromal_cells"	"percent_tumor_cells"	"batch"	"uncurated_author_metadata"
"GSM657519"	"Normal HOSE2237"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2237///geo_accession: GSM657519///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657519/GSM657519_HOSE2237.CEL.gz///data_row_count: 22283"
"GSM657520"	"Normal HOSE2008"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2008///geo_accession: GSM657520///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657520/GSM657520_HOSE2008.CEL.gz///data_row_count: 22283"
"GSM657521"	"Normal HOSE2061"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2061///geo_accession: GSM657521///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657521/GSM657521_HOSE2061.CEL.gz///data_row_count: 22283"
"GSM657522"	"Normal HOSE2064"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2064///geo_accession: GSM657522///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657522/GSM657522_HOSE2064.CEL.gz///data_row_count: 22283"
"GSM657523"	"Normal HOSE2085"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2085///geo_accession: GSM657523///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657523/GSM657523_HOSE2085.CEL.gz///data_row_count: 22283"
"GSM657524"	"Normal HOSE2225"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2225///geo_accession: GSM657524///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657524/GSM657524_HOSE2225.CEL.gz///data_row_count: 22283"
"GSM657525"	"Normal HOSE2226"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2226///geo_accession: GSM657525///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657525/GSM657525_HOSE2226.CEL.gz///data_row_count: 22283"
"GSM657526"	"Normal HOSE2228"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2228///geo_accession: GSM657526///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657526/GSM657526_HOSE2228.CEL.gz///data_row_count: 22283"
"GSM657527"	"Normal HOSE2230"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2230///geo_accession: GSM657527///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657527/GSM657527_HOSE2230.CEL.gz///data_row_count: 22283"
"GSM657528"	"Normal HOSE2234"	NA	"healthy"	NA	"ov"	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	NA	NA	NA	NA	NA	"20-"	"20-"	"80+"	"2006-11-09"	"title: Normal HOSE2234///geo_accession: GSM657528///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian surface epithelial cells///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Normal ovarian surface epithelium///characteristics_ch1.1: ///characteristics_ch1.2: ///characteristics_ch1.3: ///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from ovarian surface epithelial cells///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657528/GSM657528_HOSE2234.CEL.gz///data_row_count: 22283"
"GSM657529"	"Ovarian Cancer SO10"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	43	NA	NA	NA	NA	"recurrence"	2730.2	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO10///geo_accession: GSM657529///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 7.48///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657529/GSM657529_SO10.CEL.gz///data_row_count: 22283"
"GSM657530"	"Ovarian Cancer SO100"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	53	NA	NA	NA	NA	"norecurrence"	1646.15	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-06"	"title: Ovarian Cancer SO100///geo_accession: GSM657530///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.51///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657530/GSM657530_SO100.CEL.gz///data_row_count: 22283"
"GSM657531"	"Ovarian Cancer SO103"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	41	NA	NA	NA	NA	"norecurrence"	1598.7	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-06"	"title: Ovarian Cancer SO103///geo_accession: GSM657531///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.38///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657531/GSM657531_SO103.CEL.gz///data_row_count: 22283"
"GSM657532"	"Ovarian Cancer SO106"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	48	NA	NA	NA	NA	"recurrence"	627.8	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO106///geo_accession: GSM657532///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.72///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657532/GSM657532_SO106.CEL.gz///data_row_count: 22283"
"GSM657533"	"Ovarian Cancer SO108"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	49	NA	NA	NA	NA	"recurrence"	1456.35	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-06"	"title: Ovarian Cancer SO108///geo_accession: GSM657533///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.99///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657533/GSM657533_SO108.CEL.gz///data_row_count: 22283"
"GSM657534"	"Ovarian Cancer SO11"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	53	NA	NA	NA	NA	"recurrence"	916.15	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO11///geo_accession: GSM657534///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.51///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657534/GSM657534_SO11.CEL.gz///data_row_count: 22283"
"GSM657535"	"Ovarian Cancer SO113"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	76	NA	NA	NA	NA	"norecurrence"	1376.05	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-06"	"title: Ovarian Cancer SO113///geo_accession: GSM657535///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 3.77///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657535/GSM657535_SO113.CEL.gz///data_row_count: 22283"
"GSM657536"	"Ovarian Cancer SO115"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	68	NA	NA	NA	NA	"recurrence"	894.25	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-06"	"title: Ovarian Cancer SO115///geo_accession: GSM657536///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.45///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657536/GSM657536_SO115.CEL.gz///data_row_count: 22283"
"GSM657537"	"Ovarian Cancer SO116"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	61	NA	NA	NA	NA	"recurrence"	1306.7	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO116///geo_accession: GSM657537///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.58///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657537/GSM657537_SO116.CEL.gz///data_row_count: 22283"
"GSM657538"	"Ovarian Cancer SO117"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	51	NA	NA	NA	NA	"recurrence"	1288.45	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-06"	"title: Ovarian Cancer SO117///geo_accession: GSM657538///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.53///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657538/GSM657538_SO117.CEL.gz///data_row_count: 22283"
"GSM657539"	"Ovarian Cancer SO118"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	59	NA	NA	NA	NA	"recurrence"	1273.85	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-06"	"title: Ovarian Cancer SO118///geo_accession: GSM657539///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.49///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657539/GSM657539_SO118.CEL.gz///data_row_count: 22283"
"GSM657540"	"Ovarian Cancer SO12"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	75	NA	NA	NA	NA	"recurrence"	259.15	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO12///geo_accession: GSM657540///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.71///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657540/GSM657540_SO12.CEL.gz///data_row_count: 22283"
"GSM657541"	"Ovarian Cancer SO121"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	70	NA	NA	NA	NA	"norecurrence"	1204.5	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-07"	"title: Ovarian Cancer SO121///geo_accession: GSM657541///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 3.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657541/GSM657541_SO121.CEL.gz///data_row_count: 22283"
"GSM657542"	"Ovarian Cancer SO122"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	81	NA	NA	NA	NA	"recurrence"	839.5	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-06"	"title: Ovarian Cancer SO122///geo_accession: GSM657542///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657542/GSM657542_SO122.CEL.gz///data_row_count: 22283"
"GSM657543"	"Ovarian Cancer SO124"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"norecurrence"	1189.9	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-07"	"title: Ovarian Cancer SO124///geo_accession: GSM657543///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 3.26///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657543/GSM657543_SO124.CEL.gz///data_row_count: 22283"
"GSM657544"	"Ovarian Cancer SO129"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	45	NA	NA	NA	NA	"norecurrence"	1029.3	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-07"	"title: Ovarian Cancer SO129///geo_accession: GSM657544///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.82///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657544/GSM657544_SO129.CEL.gz///data_row_count: 22283"
"GSM657545"	"Ovarian Cancer SO13"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	71	NA	NA	NA	NA	"norecurrence"	2675.45	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO13///geo_accession: GSM657545///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 7.33///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657545/GSM657545_SO13.CEL.gz///data_row_count: 22283"
"GSM657546"	"Ovarian Cancer SO131"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	46	NA	NA	NA	NA	"norecurrence"	1073.1	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-07"	"title: Ovarian Cancer SO131///geo_accession: GSM657546///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657546/GSM657546_SO131.CEL.gz///data_row_count: 22283"
"GSM657547"	"Ovarian Cancer SO134"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	44	NA	NA	NA	NA	"recurrence"	375.95	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-07"	"title: Ovarian Cancer SO134///geo_accession: GSM657547///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.03///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657547/GSM657547_SO134.CEL.gz///data_row_count: 22283"
"GSM657548"	"Ovarian Cancer SO135"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	55	NA	NA	NA	NA	"recurrence"	1295.75	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO135///geo_accession: GSM657548///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.55///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657548/GSM657548_SO135.CEL.gz///data_row_count: 22283"
"GSM657549"	"Ovarian Cancer SO137"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	75	NA	NA	NA	NA	"recurrence"	62.05	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-07"	"title: Ovarian Cancer SO137///geo_accession: GSM657549///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.17///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657549/GSM657549_SO137.CEL.gz///data_row_count: 22283"
"GSM657550"	"Ovarian Cancer SO141"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	69	NA	NA	NA	NA	"recurrence"	536.55	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO141///geo_accession: GSM657550///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.47///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657550/GSM657550_SO141.CEL.gz///data_row_count: 22283"
"GSM657551"	"Ovarian Cancer SO143"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	48	NA	NA	NA	NA	"recurrence"	2503.9	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO143///geo_accession: GSM657551///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 6.86///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657551/GSM657551_SO143.CEL.gz///data_row_count: 22283"
"GSM657552"	"Ovarian Cancer SO148"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	51	NA	NA	NA	NA	"recurrence"	865.05	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO148///geo_accession: GSM657552///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.37///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657552/GSM657552_SO148.CEL.gz///data_row_count: 22283"
"GSM657553"	"Ovarian Cancer SO154"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	47	NA	NA	NA	NA	"recurrence"	1350.5	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO154///geo_accession: GSM657553///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 3.7///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657553/GSM657553_SO154.CEL.gz///data_row_count: 22283"
"GSM657554"	"Ovarian Cancer SO16"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	51	NA	NA	NA	NA	"recurrence"	2295.85	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO16///geo_accession: GSM657554///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.29///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657554/GSM657554_SO16.CEL.gz///data_row_count: 22283"
"GSM657555"	"Ovarian Cancer SO166"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	67	NA	NA	NA	NA	"norecurrence"	1069.45	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO166///geo_accession: GSM657555///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.93///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657555/GSM657555_SO166.CEL.gz///data_row_count: 22283"
"GSM657556"	"Ovarian Cancer SO17"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	55	NA	NA	NA	NA	"recurrence"	1397.95	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO17///geo_accession: GSM657556///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.83///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657556/GSM657556_SO17.CEL.gz///data_row_count: 22283"
"GSM657557"	"Ovarian Cancer SO173"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	42	NA	NA	NA	NA	"recurrence"	989.15	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO173///geo_accession: GSM657557///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.71///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657557/GSM657557_SO173.CEL.gz///data_row_count: 22283"
"GSM657558"	"Ovarian Cancer SO174"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	56	NA	NA	NA	NA	"recurrence"	1036.6	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO174///geo_accession: GSM657558///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.84///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657558/GSM657558_SO174.CEL.gz///data_row_count: 22283"
"GSM657559"	"Ovarian Cancer SO18"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	NA	41	NA	NA	NA	NA	"recurrence"	2299.5	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO18///geo_accession: GSM657559///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657559/GSM657559_SO18.CEL.gz///data_row_count: 22283"
"GSM657560"	"Ovarian Cancer SO181"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	56	NA	NA	NA	NA	"norecurrence"	766.5	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO181///geo_accession: GSM657560///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.1///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657560/GSM657560_SO181.CEL.gz///data_row_count: 22283"
"GSM657561"	"Ovarian Cancer SO184"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	78	NA	NA	NA	NA	"norecurrence"	886.95	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO184///geo_accession: GSM657561///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.43///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657561/GSM657561_SO184.CEL.gz///data_row_count: 22283"
"GSM657562"	"Ovarian Cancer SO185"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	75	NA	NA	NA	NA	"norecurrence"	865.05	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO185///geo_accession: GSM657562///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.37///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657562/GSM657562_SO185.CEL.gz///data_row_count: 22283"
"GSM657563"	"Ovarian Cancer SO187"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"recurrence"	905.2	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO187///geo_accession: GSM657563///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.48///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657563/GSM657563_SO187.CEL.gz///data_row_count: 22283"
"GSM657564"	"Ovarian Cancer SO189"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	56	NA	NA	NA	NA	"norecurrence"	839.5	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO189///geo_accession: GSM657564///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 2.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657564/GSM657564_SO189.CEL.gz///data_row_count: 22283"
"GSM657565"	"Ovarian Cancer SO190"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	69	NA	NA	NA	NA	"recurrence"	788.4	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO190///geo_accession: GSM657565///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.16///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657565/GSM657565_SO190.CEL.gz///data_row_count: 22283"
"GSM657566"	"Ovarian Cancer SO193"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	66	NA	NA	NA	NA	"recurrence"	828.55	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO193///geo_accession: GSM657566///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.27///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657566/GSM657566_SO193.CEL.gz///data_row_count: 22283"
"GSM657567"	"Ovarian Cancer SO194"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	71	NA	NA	NA	NA	"recurrence"	813.95	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO194///geo_accession: GSM657567///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.23///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657567/GSM657567_SO194.CEL.gz///data_row_count: 22283"
"GSM657568"	"Ovarian Cancer SO196"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	71	NA	NA	NA	NA	"recurrence"	467.2	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO196///geo_accession: GSM657568///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.28///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657568/GSM657568_SO196.CEL.gz///data_row_count: 22283"
"GSM657569"	"Ovarian Cancer SO197"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	NA	71	NA	NA	NA	NA	"recurrence"	788.4	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO197///geo_accession: GSM657569///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.16///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657569/GSM657569_SO197.CEL.gz///data_row_count: 22283"
"GSM657570"	"Ovarian Cancer SO2"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	46	NA	NA	NA	NA	"recurrence"	1032.95	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO2///geo_accession: GSM657570///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.83///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657570/GSM657570_SO2.CEL.gz///data_row_count: 22283"
"GSM657571"	"Ovarian Cancer SO200"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	74	NA	NA	NA	NA	"recurrence"	784.75	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO200///geo_accession: GSM657571///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.15///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657571/GSM657571_SO200.CEL.gz///data_row_count: 22283"
"GSM657572"	"Ovarian Cancer SO201"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	70	NA	NA	NA	NA	"recurrence"	751.9	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO201///geo_accession: GSM657572///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 2.06///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657572/GSM657572_SO201.CEL.gz///data_row_count: 22283"
"GSM657573"	"Ovarian Cancer SO203"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	70	NA	NA	NA	NA	"recurrence"	580.35	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO203///geo_accession: GSM657573///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.59///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657573/GSM657573_SO203.CEL.gz///data_row_count: 22283"
"GSM657574"	"Ovarian Cancer SO205"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	61	NA	NA	NA	NA	"norecurrence"	689.85	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-21"	"title: Ovarian Cancer SO205///geo_accession: GSM657574///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 1.89///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657574/GSM657574_SO205.CEL.gz///data_row_count: 22283"
"GSM657575"	"Ovarian Cancer SO21"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	NA	66	NA	NA	NA	NA	"recurrence"	204.4	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO21///geo_accession: GSM657575///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.56///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657575/GSM657575_SO21.CEL.gz///data_row_count: 22283"
"GSM657576"	"Ovarian Cancer SO211"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	71	NA	NA	NA	NA	"recurrence"	1803.1	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO211///geo_accession: GSM657576///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657576/GSM657576_SO211.CEL.gz///data_row_count: 22283"
"GSM657577"	"Ovarian Cancer SO214"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"recurrence"	1080.4	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO214///geo_accession: GSM657577///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.96///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657577/GSM657577_SO214.CEL.gz///data_row_count: 22283"
"GSM657578"	"Ovarian Cancer SO216"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	70	NA	NA	NA	NA	"recurrence"	638.75	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO216///geo_accession: GSM657578///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.75///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657578/GSM657578_SO216.CEL.gz///data_row_count: 22283"
"GSM657579"	"Ovarian Cancer SO217"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	75	NA	NA	NA	NA	"recurrence"	697.15	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO217///geo_accession: GSM657579///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.91///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657579/GSM657579_SO217.CEL.gz///data_row_count: 22283"
"GSM657580"	"Ovarian Cancer SO218"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	78	NA	NA	NA	NA	"recurrence"	1679	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO218///geo_accession: GSM657580///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.6///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657580/GSM657580_SO218.CEL.gz///data_row_count: 22283"
"GSM657581"	"Ovarian Cancer SO224"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	71	NA	NA	NA	NA	"recurrence"	1160.7	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO224///geo_accession: GSM657581///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.18///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657581/GSM657581_SO224.CEL.gz///data_row_count: 22283"
"GSM657582"	"Ovarian Cancer SO225"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	45	NA	NA	NA	NA	"recurrence"	3212	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO225///geo_accession: GSM657582///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 8.8///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657582/GSM657582_SO225.CEL.gz///data_row_count: 22283"
"GSM657583"	"Ovarian Cancer SO227"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	72	NA	NA	NA	NA	"recurrence"	2073.2	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO227///geo_accession: GSM657583///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.68///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657583/GSM657583_SO227.CEL.gz///data_row_count: 22283"
"GSM657584"	"Ovarian Cancer SO228"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	78	NA	NA	NA	NA	"recurrence"	2463.75	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO228///geo_accession: GSM657584///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.75///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657584/GSM657584_SO228.CEL.gz///data_row_count: 22283"
"GSM657585"	"Ovarian Cancer SO229"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	58	NA	NA	NA	NA	"recurrence"	313.9	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO229///geo_accession: GSM657585///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.86///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657585/GSM657585_SO229.CEL.gz///data_row_count: 22283"
"GSM657586"	"Ovarian Cancer SO23"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"norecurrence"	2522.15	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO23///geo_accession: GSM657586///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 6.91///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657586/GSM657586_SO23.CEL.gz///data_row_count: 22283"
"GSM657587"	"Ovarian Cancer SO230"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	52	NA	NA	NA	NA	"recurrence"	1328.6	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO230///geo_accession: GSM657587///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.64///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657587/GSM657587_SO230.CEL.gz///data_row_count: 22283"
"GSM657588"	"Ovarian Cancer SO231"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	68	NA	NA	NA	NA	"recurrence"	1879.75	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO231///geo_accession: GSM657588///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.15///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657588/GSM657588_SO231.CEL.gz///data_row_count: 22283"
"GSM657589"	"Ovarian Cancer SO235"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	51	NA	NA	NA	NA	"recurrence"	226.3	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO235///geo_accession: GSM657589///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.62///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657589/GSM657589_SO235.CEL.gz///data_row_count: 22283"
"GSM657590"	"Ovarian Cancer SO236"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	26	NA	NA	NA	NA	"norecurrence"	4927.5	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO236///geo_accession: GSM657590///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 13.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657590/GSM657590_SO236.CEL.gz///data_row_count: 22283"
"GSM657591"	"Ovarian Cancer SO237"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	77	NA	NA	NA	NA	"recurrence"	215.35	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO237///geo_accession: GSM657591///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.59///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657591/GSM657591_SO237.CEL.gz///data_row_count: 22283"
"GSM657592"	"Ovarian Cancer SO241"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	30	NA	NA	NA	NA	"recurrence"	1138.8	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO241///geo_accession: GSM657592///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.12///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657592/GSM657592_SO241.CEL.gz///data_row_count: 22283"
"GSM657593"	"Ovarian Cancer SO242"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	84	NA	NA	NA	NA	"recurrence"	76.65	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO242///geo_accession: GSM657593///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.21///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657593/GSM657593_SO242.CEL.gz///data_row_count: 22283"
"GSM657594"	"Ovarian Cancer SO243"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	62	NA	NA	NA	NA	"norecurrence"	4781.5	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO243///geo_accession: GSM657594///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 13.1///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657594/GSM657594_SO243.CEL.gz///data_row_count: 22283"
"GSM657595"	"Ovarian Cancer SO244"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	66	NA	NA	NA	NA	"recurrence"	361.35	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO244///geo_accession: GSM657595///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.99///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657595/GSM657595_SO244.CEL.gz///data_row_count: 22283"
"GSM657596"	"Ovarian Cancer SO246"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	41	NA	NA	NA	NA	"recurrence"	1441.75	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO246///geo_accession: GSM657596///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.95///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657596/GSM657596_SO246.CEL.gz///data_row_count: 22283"
"GSM657597"	"Ovarian Cancer SO247"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	57	NA	NA	NA	NA	"recurrence"	1949.1	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO247///geo_accession: GSM657597///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.34///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657597/GSM657597_SO247.CEL.gz///data_row_count: 22283"
"GSM657598"	"Ovarian Cancer SO249"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	66	NA	NA	NA	NA	"recurrence"	2492.95	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO249///geo_accession: GSM657598///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.83///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657598/GSM657598_SO249.CEL.gz///data_row_count: 22283"
"GSM657599"	"Ovarian Cancer SO25"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	54	NA	NA	NA	NA	"recurrence"	1277.5	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO25///geo_accession: GSM657599///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657599/GSM657599_SO25.CEL.gz///data_row_count: 22283"
"GSM657600"	"Ovarian Cancer SO250"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	62	NA	NA	NA	NA	"recurrence"	3153.6	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO250///geo_accession: GSM657600///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 8.64///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657600/GSM657600_SO250.CEL.gz///data_row_count: 22283"
"GSM657601"	"Ovarian Cancer SO256"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	73	NA	NA	NA	NA	"recurrence"	708.1	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO256///geo_accession: GSM657601///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657601/GSM657601_SO256.CEL.gz///data_row_count: 22283"
"GSM657602"	"Ovarian Cancer SO257"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	36	NA	NA	NA	NA	"recurrence"	803	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO257///geo_accession: GSM657602///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.2///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657602/GSM657602_SO257.CEL.gz///data_row_count: 22283"
"GSM657603"	"Ovarian Cancer SO258"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	62	NA	NA	NA	NA	"recurrence"	627.8	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO258///geo_accession: GSM657603///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.72///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657603/GSM657603_SO258.CEL.gz///data_row_count: 22283"
"GSM657604"	"Ovarian Cancer SO261"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	67	NA	NA	NA	NA	"recurrence"	357.7	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO261///geo_accession: GSM657604///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.98///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657604/GSM657604_SO261.CEL.gz///data_row_count: 22283"
"GSM657605"	"Ovarian Cancer SO262"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	61	NA	NA	NA	NA	"recurrence"	2876.2	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-23"	"title: Ovarian Cancer SO262///geo_accession: GSM657605///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 7.88///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657605/GSM657605_SO262.CEL.gz///data_row_count: 22283"
"GSM657606"	"Ovarian Cancer SO263"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	44	NA	NA	NA	NA	"recurrence"	1434.45	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO263///geo_accession: GSM657606///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.93///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657606/GSM657606_SO263.CEL.gz///data_row_count: 22283"
"GSM657607"	"Ovarian Cancer SO265"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	65	NA	NA	NA	NA	"recurrence"	120.45	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO265///geo_accession: GSM657607///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.33///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657607/GSM657607_SO265.CEL.gz///data_row_count: 22283"
"GSM657608"	"Ovarian Cancer SO267"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	52	NA	NA	NA	NA	"recurrence"	474.5	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO267///geo_accession: GSM657608///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.3///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657608/GSM657608_SO267.CEL.gz///data_row_count: 22283"
"GSM657609"	"Ovarian Cancer SO268"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	70	NA	NA	NA	NA	"recurrence"	3365.3	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO268///geo_accession: GSM657609///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 9.22///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657609/GSM657609_SO268.CEL.gz///data_row_count: 22283"
"GSM657610"	"Ovarian Cancer SO272"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	51	NA	NA	NA	NA	"recurrence"	1368.75	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO272///geo_accession: GSM657610///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.75///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657610/GSM657610_SO272.CEL.gz///data_row_count: 22283"
"GSM657611"	"Ovarian Cancer SO273"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	81	NA	NA	NA	NA	"recurrence"	919.8	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO273///geo_accession: GSM657611///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.52///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657611/GSM657611_SO273.CEL.gz///data_row_count: 22283"
"GSM657612"	"Ovarian Cancer SO278"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	61	NA	NA	NA	NA	"recurrence"	1653.45	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO278///geo_accession: GSM657612///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.53///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657612/GSM657612_SO278.CEL.gz///data_row_count: 22283"
"GSM657613"	"Ovarian Cancer SO279"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	79	NA	NA	NA	NA	"recurrence"	335.8	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO279///geo_accession: GSM657613///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.92///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657613/GSM657613_SO279.CEL.gz///data_row_count: 22283"
"GSM657614"	"Ovarian Cancer SO282"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	52	NA	NA	NA	NA	"recurrence"	876	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO282///geo_accession: GSM657614///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.4///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657614/GSM657614_SO282.CEL.gz///data_row_count: 22283"
"GSM657615"	"Ovarian Cancer SO283"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	56	NA	NA	NA	NA	"recurrence"	240.9	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO283///geo_accession: GSM657615///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.66///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657615/GSM657615_SO283.CEL.gz///data_row_count: 22283"
"GSM657616"	"Ovarian Cancer SO285"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"recurrence"	846.8	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO285///geo_accession: GSM657616///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.32///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657616/GSM657616_SO285.CEL.gz///data_row_count: 22283"
"GSM657617"	"Ovarian Cancer SO290"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	83	NA	NA	NA	NA	"recurrence"	1277.5	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO290///geo_accession: GSM657617///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657617/GSM657617_SO290.CEL.gz///data_row_count: 22283"
"GSM657618"	"Ovarian Cancer SO295"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	64	NA	NA	NA	NA	"recurrence"	1182.6	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO295///geo_accession: GSM657618///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.24///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657618/GSM657618_SO295.CEL.gz///data_row_count: 22283"
"GSM657619"	"Ovarian Cancer SO299"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	66	NA	NA	NA	NA	"recurrence"	21.9	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO299///geo_accession: GSM657619///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.06///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657619/GSM657619_SO299.CEL.gz///data_row_count: 22283"
"GSM657620"	"Ovarian Cancer SO300"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	43	NA	NA	NA	NA	"norecurrence"	131.4	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO300///geo_accession: GSM657620///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 0.36///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657620/GSM657620_SO300.CEL.gz///data_row_count: 22283"
"GSM657621"	"Ovarian Cancer SO301"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	67	NA	NA	NA	NA	"recurrence"	1091.35	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO301///geo_accession: GSM657621///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.99///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657621/GSM657621_SO301.CEL.gz///data_row_count: 22283"
"GSM657622"	"Ovarian Cancer SO303"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	72	NA	NA	NA	NA	"recurrence"	565.75	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO303///geo_accession: GSM657622///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.55///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657622/GSM657622_SO303.CEL.gz///data_row_count: 22283"
"GSM657623"	"Ovarian Cancer SO308"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	76	NA	NA	NA	NA	"recurrence"	1762.95	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO308///geo_accession: GSM657623///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.83///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657623/GSM657623_SO308.CEL.gz///data_row_count: 22283"
"GSM657624"	"Ovarian Cancer SO31"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	45	NA	NA	NA	NA	"recurrence"	1503.8	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO31///geo_accession: GSM657624///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.12///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657624/GSM657624_SO31.CEL.gz///data_row_count: 22283"
"GSM657625"	"Ovarian Cancer SO312"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	53	NA	NA	NA	NA	"recurrence"	569.4	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-24"	"title: Ovarian Cancer SO312///geo_accession: GSM657625///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.56///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657625/GSM657625_SO312.CEL.gz///data_row_count: 22283"
"GSM657626"	"Ovarian Cancer SO322"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"recurrence"	1456.35	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-27"	"title: Ovarian Cancer SO322///geo_accession: GSM657626///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.99///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657626/GSM657626_SO322.CEL.gz///data_row_count: 22283"
"GSM657627"	"Ovarian Cancer SO325"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	59	NA	NA	NA	NA	"recurrence"	113.15	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-27"	"title: Ovarian Cancer SO325///geo_accession: GSM657627///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.31///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657627/GSM657627_SO325.CEL.gz///data_row_count: 22283"
"GSM657628"	"Ovarian Cancer SO334"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	64	NA	NA	NA	NA	"recurrence"	127.75	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-27"	"title: Ovarian Cancer SO334///geo_accession: GSM657628///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.35///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657628/GSM657628_SO334.CEL.gz///data_row_count: 22283"
"GSM657629"	"Ovarian Cancer SO342"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	61	NA	NA	NA	NA	"recurrence"	1054.85	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO342///geo_accession: GSM657629///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.89///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657629/GSM657629_SO342.CEL.gz///data_row_count: 22283"
"GSM657630"	"Ovarian Cancer SO347"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	46	NA	NA	NA	NA	"recurrence"	2865.25	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO347///geo_accession: GSM657630///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 7.85///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657630/GSM657630_SO347.CEL.gz///data_row_count: 22283"
"GSM657631"	"Ovarian Cancer SO36"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	45	NA	NA	NA	NA	"recurrence"	1602.35	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO36///geo_accession: GSM657631///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 4.39///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657631/GSM657631_SO36RE.CEL.gz///data_row_count: 22283"
"GSM657632"	"Ovarian Cancer SO362"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	62	NA	NA	NA	NA	"recurrence"	1295.75	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO362///geo_accession: GSM657632///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.55///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657632/GSM657632_SO362.CEL.gz///data_row_count: 22283"
"GSM657633"	"Ovarian Cancer SO367"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"recurrence"	2376.15	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO367///geo_accession: GSM657633///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.51///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657633/GSM657633_SO367.CEL.gz///data_row_count: 22283"
"GSM657634"	"Ovarian Cancer SO375"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	NA	43	NA	NA	NA	NA	"norecurrence"	2963.8	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO375///geo_accession: GSM657634///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 8.12///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657634/GSM657634_SO375.CEL.gz///data_row_count: 22283"
"GSM657635"	"Ovarian Cancer SO38"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	NA	77	NA	NA	NA	NA	"recurrence"	1000.1	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO38///geo_accession: GSM657635///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.74///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657635/GSM657635_SO38.CEL.gz///data_row_count: 22283"
"GSM657636"	"Ovarian Cancer SO387"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	66	NA	NA	NA	NA	"recurrence"	536.55	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO387///geo_accession: GSM657636///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.47///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657636/GSM657636_SO387.CEL.gz///data_row_count: 22283"
"GSM657637"	"Ovarian Cancer SO388"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	69	NA	NA	NA	NA	"recurrence"	354.05	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO388///geo_accession: GSM657637///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.97///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657637/GSM657637_SO388.CEL.gz///data_row_count: 22283"
"GSM657638"	"Ovarian Cancer SO393"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	58	NA	NA	NA	NA	"recurrence"	1441.75	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO393///geo_accession: GSM657638///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.95///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657638/GSM657638_SO393.CEL.gz///data_row_count: 22283"
"GSM657639"	"Ovarian Cancer SO395"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	83	NA	NA	NA	NA	"recurrence"	1449.05	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO395///geo_accession: GSM657639///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.97///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657639/GSM657639_SO395.CEL.gz///data_row_count: 22283"
"GSM657640"	"Ovarian Cancer SO396"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	71	NA	NA	NA	NA	"recurrence"	616.85	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO396///geo_accession: GSM657640///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.69///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657640/GSM657640_SO396.CEL.gz///data_row_count: 22283"
"GSM657641"	"Ovarian Cancer SO4"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	75	NA	NA	NA	NA	"recurrence"	299.3	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO4///geo_accession: GSM657641///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.82///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657641/GSM657641_SO4.CEL.gz///data_row_count: 22283"
"GSM657642"	"Ovarian Cancer SO400"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	58	NA	NA	NA	NA	"norecurrence"	3682.85	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO400///geo_accession: GSM657642///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 10.09///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657642/GSM657642_SO400.CEL.gz///data_row_count: 22283"
"GSM657643"	"Ovarian Cancer SO401"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	82	NA	NA	NA	NA	"recurrence"	540.2	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO401///geo_accession: GSM657643///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.48///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657643/GSM657643_SO401.CEL.gz///data_row_count: 22283"
"GSM657644"	"Ovarian Cancer SO402"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	70	NA	NA	NA	NA	"recurrence"	3664.6	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO402///geo_accession: GSM657644///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 10.04///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657644/GSM657644_SO402.CEL.gz///data_row_count: 22283"
"GSM657645"	"Ovarian Cancer SO404"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	69	NA	NA	NA	NA	"recurrence"	215.35	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO404///geo_accession: GSM657645///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.59///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657645/GSM657645_SO404.CEL.gz///data_row_count: 22283"
"GSM657646"	"Ovarian Cancer SO409"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	60	NA	NA	NA	NA	"recurrence"	1343.2	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-21"	"title: Ovarian Cancer SO409///geo_accession: GSM657646///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.68///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657646/GSM657646_SO409.CEL.gz///data_row_count: 22283"
"GSM657647"	"Ovarian Cancer SO418"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	75	NA	NA	NA	NA	"recurrence"	489.1	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-27"	"title: Ovarian Cancer SO418///geo_accession: GSM657647///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.34///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657647/GSM657647_SO418.CEL.gz///data_row_count: 22283"
"GSM657648"	"Ovarian Cancer SO420"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	39	NA	NA	NA	NA	"recurrence"	3292.3	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-27"	"title: Ovarian Cancer SO420///geo_accession: GSM657648///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 9.02///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657648/GSM657648_SO420.CEL.gz///data_row_count: 22283"
"GSM657649"	"Ovarian Cancer SO420b"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	NA	NA	NA	NA	NA	NA	NA	NA	"recurrence"	401.5	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO420b///geo_accession: GSM657649///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.1///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657649/GSM657649_SO420b.CEL.gz///data_row_count: 22283"
"GSM657650"	"Ovarian Cancer SO421"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	60	NA	NA	NA	NA	"recurrence"	938.05	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO421///geo_accession: GSM657650///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.57///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657650/GSM657650_SO421.CEL.gz///data_row_count: 22283"
"GSM657651"	"Ovarian Cancer SO422"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	48	NA	NA	NA	NA	"recurrence"	719.05	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-27"	"title: Ovarian Cancer SO422///geo_accession: GSM657651///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.97///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657651/GSM657651_SO422.CEL.gz///data_row_count: 22283"
"GSM657652"	"Ovarian Cancer SO422b"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	NA	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	4982.25	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO422b///geo_accession: GSM657652///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 13.65///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657652/GSM657652_SO422b.CEL.gz///data_row_count: 22283"
"GSM657653"	"Ovarian Cancer SO423"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	60	NA	NA	NA	NA	"recurrence"	4912.9	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO423///geo_accession: GSM657653///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 13.46///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657653/GSM657653_SO423.CEL.gz///data_row_count: 22283"
"GSM657654"	"Ovarian Cancer SO426"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	NA	64	NA	NA	NA	NA	"recurrence"	4927.5	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO426///geo_accession: GSM657654///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 13.5///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657654/GSM657654_SO426.CEL.gz///data_row_count: 22283"
"GSM657655"	"Ovarian Cancer SO428"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	48	NA	NA	NA	NA	"recurrence"	956.3	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-27"	"title: Ovarian Cancer SO428///geo_accession: GSM657655///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.62///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657655/GSM657655_SO428.CEL.gz///data_row_count: 22283"
"GSM657656"	"Ovarian Cancer SO428b"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	NA	NA	NA	NA	NA	NA	NA	NA	"recurrence"	1365.1	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO428b///geo_accession: GSM657656///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.74///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657656/GSM657656_SO428b.CEL.gz///data_row_count: 22283"
"GSM657657"	"Ovarian Cancer SO429"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	71	NA	NA	NA	NA	"recurrence"	923.45	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-27"	"title: Ovarian Cancer SO429///geo_accession: GSM657657///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.53///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657657/GSM657657_SO429.CEL.gz///data_row_count: 22283"
"GSM657658"	"Ovarian Cancer SO434"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	66	NA	NA	NA	NA	"recurrence"	722.7	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-27"	"title: Ovarian Cancer SO434///geo_accession: GSM657658///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.98///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657658/GSM657658_SO434.CEL.gz///data_row_count: 22283"
"GSM657659"	"Ovarian Cancer SO44"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	57	NA	NA	NA	NA	"norecurrence"	2306.8	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO44///geo_accession: GSM657659///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 6.32///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657659/GSM657659_SO44.CEL.gz///data_row_count: 22283"
"GSM657660"	"Ovarian Cancer SO46"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	61	NA	NA	NA	NA	"recurrence"	299.3	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO46///geo_accession: GSM657660///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.82///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657660/GSM657660_SO46.CEL.gz///data_row_count: 22283"
"GSM657661"	"Ovarian Cancer SO475"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	61	NA	NA	NA	NA	"recurrence"	1164.35	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO475///geo_accession: GSM657661///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.19///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657661/GSM657661_SO475.CEL.gz///data_row_count: 22283"
"GSM657662"	"Ovarian Cancer SO479"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	54	NA	NA	NA	NA	"recurrence"	2153.5	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO479///geo_accession: GSM657662///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.9///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657662/GSM657662_SO479.CEL.gz///data_row_count: 22283"
"GSM657663"	"Ovarian Cancer SO481"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"recurrence"	1781.2	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO481///geo_accession: GSM657663///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.88///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657663/GSM657663_SO481.CEL.gz///data_row_count: 22283"
"GSM657664"	"Ovarian Cancer SO483"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	76	NA	NA	NA	NA	"recurrence"	146	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO483///geo_accession: GSM657664///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.4///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657664/GSM657664_SO483.CEL.gz///data_row_count: 22283"
"GSM657665"	"Ovarian Cancer SO487"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	NA	67	NA	NA	NA	NA	"recurrence"	2635.3	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO487///geo_accession: GSM657665///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 7.22///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657665/GSM657665_SO487.CEL.gz///data_row_count: 22283"
"GSM657666"	"Ovarian Cancer SO489"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	60	NA	NA	NA	NA	"recurrence"	1974.65	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO489///geo_accession: GSM657666///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.41///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657666/GSM657666_SO489.CEL.gz///data_row_count: 22283"
"GSM657667"	"Ovarian Cancer SO490"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	66	NA	NA	NA	NA	"recurrence"	3916.45	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO490///geo_accession: GSM657667///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 10.73///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657667/GSM657667_SO490.CEL.gz///data_row_count: 22283"
"GSM657668"	"Ovarian Cancer SO5"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	60	NA	NA	NA	NA	"recurrence"	2711.95	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO5///geo_accession: GSM657668///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 7.43///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657668/GSM657668_SO5.CEL.gz///data_row_count: 22283"
"GSM657669"	"Ovarian Cancer SO500"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	52	NA	NA	NA	NA	"recurrence"	850.45	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO500///geo_accession: GSM657669///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.33///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657669/GSM657669_SO500.CEL.gz///data_row_count: 22283"
"GSM657670"	"Ovarian Cancer SO501"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	45	NA	NA	NA	NA	"recurrence"	3967.55	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO501///geo_accession: GSM657670///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 10.87///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657670/GSM657670_SO501.CEL.gz///data_row_count: 22283"
"GSM657671"	"Ovarian Cancer SO502"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	48	NA	NA	NA	NA	"recurrence"	3087.9	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO502///geo_accession: GSM657671///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 8.46///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657671/GSM657671_SO502.CEL.gz///data_row_count: 22283"
"GSM657672"	"Ovarian Cancer SO504"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	42	NA	NA	NA	NA	"norecurrence"	4299.7	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO504///geo_accession: GSM657672///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 11.78///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657672/GSM657672_SO504.CEL.gz///data_row_count: 22283"
"GSM657673"	"Ovarian Cancer SO505"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	46	NA	NA	NA	NA	"norecurrence"	4230.35	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO505///geo_accession: GSM657673///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 11.59///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657673/GSM657673_SO505.CEL.gz///data_row_count: 22283"
"GSM657674"	"Ovarian Cancer SO506"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	73	NA	NA	NA	NA	"recurrence"	500.05	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO506///geo_accession: GSM657674///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.37///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657674/GSM657674_SO506.CEL.gz///data_row_count: 22283"
"GSM657675"	"Ovarian Cancer SO507"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	NA	44	NA	NA	NA	NA	"recurrence"	2485.65	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO507///geo_accession: GSM657675///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.81///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657675/GSM657675_SO507.CEL.gz///data_row_count: 22283"
"GSM657676"	"Ovarian Cancer SO509"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	77	NA	NA	NA	NA	"recurrence"	671.6	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO509///geo_accession: GSM657676///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.84///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657676/GSM657676_SO509.CEL.gz///data_row_count: 22283"
"GSM657677"	"Ovarian Cancer SO511"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	77	NA	NA	NA	NA	"recurrence"	605.9	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-09-28"	"title: Ovarian Cancer SO511///geo_accession: GSM657677///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.66///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657677/GSM657677_SO511.CEL.gz///data_row_count: 22283"
"GSM657678"	"Ovarian Cancer SO57"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	49	NA	NA	NA	NA	"recurrence"	321.2	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO57///geo_accession: GSM657678///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.88///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657678/GSM657678_SO57.CEL.gz///data_row_count: 22283"
"GSM657679"	"Ovarian Cancer SO58"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	65	NA	NA	NA	NA	"recurrence"	292	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO58///geo_accession: GSM657679///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.8///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657679/GSM657679_SO58.CEL.gz///data_row_count: 22283"
"GSM657680"	"Ovarian Cancer SO59"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	55	NA	NA	NA	NA	"recurrence"	740.95	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO59///geo_accession: GSM657680///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.03///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657680/GSM657680_SO59.CEL.gz///data_row_count: 22283"
"GSM657681"	"Ovarian Cancer SO60"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	76	NA	NA	NA	NA	"recurrence"	795.7	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO60///geo_accession: GSM657681///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.18///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657681/GSM657681_SO60.CEL.gz///data_row_count: 22283"
"GSM657682"	"Ovarian Cancer SO600"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"recurrence"	3219.3	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO600///geo_accession: GSM657682///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 8.82///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657682/GSM657682_SO600.CEL.gz///data_row_count: 22283"
"GSM657683"	"Ovarian Cancer SO603"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	55	NA	NA	NA	NA	"recurrence"	821.25	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO603///geo_accession: GSM657683///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.25///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657683/GSM657683_SO603.CEL.gz///data_row_count: 22283"
"GSM657684"	"Ovarian Cancer SO604"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	61	NA	NA	NA	NA	"recurrence"	204.4	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO604///geo_accession: GSM657684///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.56///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657684/GSM657684_SO604.CEL.gz///data_row_count: 22283"
"GSM657685"	"Ovarian Cancer SO607"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	76	NA	NA	NA	NA	"recurrence"	2511.2	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO607///geo_accession: GSM657685///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.88///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657685/GSM657685_SO607.CEL.gz///data_row_count: 22283"
"GSM657686"	"Ovarian Cancer SO609"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	70	NA	NA	NA	NA	"recurrence"	2054.95	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO609///geo_accession: GSM657686///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.63///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657686/GSM657686_SO609.CEL.gz///data_row_count: 22283"
"GSM657687"	"Ovarian Cancer SO61"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	44	NA	NA	NA	NA	"norecurrence"	2117	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO61///geo_accession: GSM657687///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 5.8///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657687/GSM657687_SO61.CEL.gz///data_row_count: 22283"
"GSM657688"	"Ovarian Cancer SO610"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	68	NA	NA	NA	NA	"recurrence"	2368.85	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO610///geo_accession: GSM657688///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.49///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657688/GSM657688_SO610.CEL.gz///data_row_count: 22283"
"GSM657689"	"Ovarian Cancer SO613"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	43	NA	NA	NA	NA	"recurrence"	2387.1	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2005-07-27"	"title: Ovarian Cancer SO613///geo_accession: GSM657689///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 6.54///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657689/GSM657689_SO613.CEL.gz///data_row_count: 22283"
"GSM657690"	"Ovarian Cancer SO67"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	77	NA	NA	NA	NA	"recurrence"	288.35	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO67///geo_accession: GSM657690///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.79///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657690/GSM657690_SO67.CEL.gz///data_row_count: 22283"
"GSM657691"	"Ovarian Cancer SO68"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	48	NA	NA	NA	NA	"norecurrence"	1981.95	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO68///geo_accession: GSM657691///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 5.43///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657691/GSM657691_SO68.CEL.gz///data_row_count: 22283"
"GSM657692"	"Ovarian Cancer SO69"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	49	NA	NA	NA	NA	"recurrence"	1660.75	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO69///geo_accession: GSM657692///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.55///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657692/GSM657692_SO69.CEL.gz///data_row_count: 22283"
"GSM657693"	"Ovarian Cancer SO7"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	49	NA	NA	NA	NA	"recurrence"	1971	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO7///geo_accession: GSM657693///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 5.4///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657693/GSM657693_SO7.CEL.gz///data_row_count: 22283"
"GSM657694"	"Ovarian Cancer SO70"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"b"	NA	60	NA	NA	NA	NA	"recurrence"	927.1	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO70///geo_accession: GSM657694///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 2.54///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657694/GSM657694_SO70.CEL.gz///data_row_count: 22283"
"GSM657695"	"Ovarian Cancer SO71"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	73	NA	NA	NA	NA	"recurrence"	1704.55	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO71///geo_accession: GSM657695///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 4.67///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657695/GSM657695_SO71.CEL.gz///data_row_count: 22283"
"GSM657696"	"Ovarian Cancer SO73"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	66	NA	NA	NA	NA	"recurrence"	1923.55	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO73///geo_accession: GSM657696///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 5.27///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657696/GSM657696_SO73.CEL.gz///data_row_count: 22283"
"GSM657697"	"Ovarian Cancer SO74"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	55	NA	NA	NA	NA	"recurrence"	189.8	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO74///geo_accession: GSM657697///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.52///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657697/GSM657697_SO74.CEL.gz///data_row_count: 22283"
"GSM657698"	"Ovarian Cancer SO76"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	61	NA	NA	NA	NA	"norecurrence"	1781.2	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO76///geo_accession: GSM657698///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.88///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657698/GSM657698_SO76RE.CEL.gz///data_row_count: 22283"
"GSM657699"	"Ovarian Cancer SO77"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	71	NA	NA	NA	NA	"recurrence"	259.15	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2004-04-20"	"title: Ovarian Cancer SO77///geo_accession: GSM657699///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.71///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657699/GSM657699_SO77.CEL.gz///data_row_count: 22283"
"GSM657700"	"Ovarian Cancer SO78"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	54	NA	NA	NA	NA	"recurrence"	1438.1	"deceased"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO78///geo_accession: GSM657700///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.94///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657700/GSM657700_SO78.CEL.gz///data_row_count: 22283"
"GSM657701"	"Ovarian Cancer SO79"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	70	NA	NA	NA	NA	"norecurrence"	1784.85	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO79///geo_accession: GSM657701///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.89///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657701/GSM657701_SO79.CEL.gz///data_row_count: 22283"
"GSM657702"	"Ovarian Cancer SO8"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	54	NA	NA	NA	NA	"recurrence"	2909.05	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-04"	"title: Ovarian Cancer SO8///geo_accession: GSM657702///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 7.97///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657702/GSM657702_SO8.CEL.gz///data_row_count: 22283"
"GSM657703"	"Ovarian Cancer SO80"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	51	NA	NA	NA	NA	"recurrence"	1627.9	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO80///geo_accession: GSM657703///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 4.46///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657703/GSM657703_SO80.CEL.gz///data_row_count: 22283"
"GSM657704"	"Ovarian Cancer SO82"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	61	NA	NA	NA	NA	"recurrence"	660.65	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO82///geo_accession: GSM657704///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.81///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657704/GSM657704_SO82.CEL.gz///data_row_count: 22283"
"GSM657705"	"Ovarian Cancer SO83"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	63	NA	NA	NA	NA	"norecurrence"	1788.5	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO83///geo_accession: GSM657705///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.9///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657705/GSM657705_SO83.CEL.gz///data_row_count: 22283"
"GSM657706"	"Ovarian Cancer SO84"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	73	NA	NA	NA	NA	"recurrence"	408.8	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO84///geo_accession: GSM657706///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 1.12///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657706/GSM657706_SO84.CEL.gz///data_row_count: 22283"
"GSM657707"	"Ovarian Cancer SO85"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	4	NA	NA	71	NA	NA	NA	NA	"recurrence"	270.1	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO85///geo_accession: GSM657707///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 0.74///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657707/GSM657707_SO85.CEL.gz///data_row_count: 22283"
"GSM657708"	"Ovarian Cancer SO86"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	65	NA	NA	NA	NA	"recurrence"	1810.4	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-12-16"	"title: Ovarian Cancer SO86///geo_accession: GSM657708///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 4.96///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657708/GSM657708_SO86RE.CEL.gz///data_row_count: 22283"
"GSM657709"	"Ovarian Cancer SO87"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	76	NA	NA	NA	NA	"norecurrence"	1730.1	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-20"	"title: Ovarian Cancer SO87///geo_accession: GSM657709///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.74///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657709/GSM657709_SO87.CEL.gz///data_row_count: 22283"
"GSM657710"	"Ovarian Cancer SO88"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	63	NA	NA	NA	NA	"norecurrence"	1737.4	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO88///geo_accession: GSM657710///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.76///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657710/GSM657710_SO88.CEL.gz///data_row_count: 22283"
"GSM657711"	"Ovarian Cancer SO89"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	66	NA	NA	NA	NA	"recurrence"	1700.9	"living"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO89///geo_accession: GSM657711///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: AWD (alive with disease)///characteristics_ch1.3: survival years: 4.66///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657711/GSM657711_SO89.CEL.gz///data_row_count: 22283"
"GSM657712"	"Ovarian Cancer SO91"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	82	NA	NA	NA	NA	"norecurrence"	1689.95	"living"	NA	NA	NA	NA	"optimal"	"20-"	"20-"	"80+"	"2003-11-05"	"title: Ovarian Cancer SO91///geo_accession: GSM657712///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Optimal///characteristics_ch1.2: status: NED (no evidence of disease)///characteristics_ch1.3: survival years: 4.63///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657712/GSM657712_SO91.CEL.gz///data_row_count: 22283"
"GSM657713"	"Ovarian Cancer SO94"	NA	"tumor"	"ser"	"ov"	NA	"high"	"late"	3	"c"	NA	69	NA	NA	NA	NA	"recurrence"	1361.45	"deceased"	NA	NA	NA	NA	"suboptimal"	"20-"	"20-"	"80+"	"2003-11-06"	"title: Ovarian Cancer SO94///geo_accession: GSM657713///status: Public on Jan 20 2011///submission_date: Jan 19 2011///last_update_date: Jan 20 2011///type: RNA///channel_count: 1///source_name_ch1: Ovarian tumor///organism_ch1: Homo sapiens///characteristics_ch1: tissue: Late-stage high-grade ovarian cancer///characteristics_ch1.1: surgery outcome: Suboptimal///characteristics_ch1.2: status: DOD (dead of disease)///characteristics_ch1.3: survival years: 3.73///treatment_protocol_ch1: Tumor specimens were obtained from 185 previously untreated late-stage (IIIIV) high-grade ovarian cancer patients. A set of 10 normal ovarian surface epithelium (OSE) cytobrushing specimens were used as control///molecule_ch1: total RNA///extract_protocol_ch1: Total RNA was isolated using the RNeasy Micro kit (Qiagen)///label_ch1: Biotin///label_protocol_ch1: Labeled amplified RNA (aRNA) for microarray analysis was generated from tumor or OSE-derived total RNA using a single round of amplification///taxid_ch1: 9606///hyb_protocol: A 15 microgram aliquot of amplified biotinylated RNA was hybridized to a Human U133 Plus 2.0 GeneChip array (Affymetrix, Santa Clara, CA).///scan_protocol: Array images were acquired using a GeneChip Scanner 3000 (Affymetrix)///description: Gene expression data from late-stage high-grade ovarian cancer///data_processing: Robust Multi-Array Analysis was performed///platform_id: GPL96///contact_name: Michael,,Birrer///contact_email: mbirrer@partners.org///contact_phone: 6177244800///contact_laboratory: Surgical Oncology Research Labs///contact_department: Medicine///contact_institute: MGH///contact_address: 70 Blossom Street///contact_city: Boston///contact_state: MA///contact_zip.postal_code: 2114///contact_country: USA///supplementary_file: ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM657nnn/GSM657713/GSM657713_SO94.CEL.gz///data_row_count: 22283"
